Introduction
Nonviral vector development has incorporated diverse technologies in attempts to mimic the efficient gene delivery capacity of viruses. The low toxicity and immunogenicity, lack of pathogenicity, and ease of pharmacologic production continue to make nonviral vectors an attractive alternative to viruses. However, nonviral vectors also continue to suffer from relatively low levels of gene transfer compared to viruses, thus the drive to improve these vectors continues.
Numerous studies on vector-cell interactions have reported that nonviral vectors bind and enter cells efficiently, but yield low gene expression. Our attention has thus been directed to the intracellular trafficking of these vectors to understand where the obstacles occur. Indeed, critical barriers exist from the assembly of the vector particle to its disassembly inside the cell. 1 Whereas particle formulation can influence how a vector interacts with the cell, our focus in this review will be on nonviral vector trafficking pathways.
Here, we will consider trafficking as the steps from cell binding to nuclear delivery. As outlined in this review, these steps can be divided into the following stages: (1) cell binding; (2) cell entry/endocytosis; (3) endosomolysis; (4) cytosolic transit toward the nucleus; and (5) nuclear entry. Importantly, we will highlight the different approaches used by researchers to overcome certain trafficking barriers to gene transfer, many of which incorporate components from biological systems that have naturally evolved the capacity to overcome such obstacles. Examples from the following different types of vectors will be featured for each trafficking step.
In this discussion, we have categorized nonviral vectors into the groupings listed in Table 1 . These groupings all share the ability to bind plasmid DNA for its transport into cells. Lipoplexes are comprised of DNA bound to cationic liposomes, which contain hydrophobic moieties thought to enable interaction with the plasma membrane. 2 Polyplexes contain hydrophilic polymers that are either linear, such as polylysine or spermine, or branched, such as polyethyleneimine (PEI) combined with DNA. [3] [4] [5] Combinations of cationic liposomes and polymers with DNA have been called lipopolyplexes. 6, 7 Molecular conjugates, in this review, will refer to combinations of peptides or proteins with DNA. These vectors may also include combinations of peptides or proteins with either of vectors 1-3 in Table 1 .
Most of these vectors compact the DNA into particles. To do this, the anionic DNA phosphate backbone must be neutralized to counteract charge repellance both from within the DNA itself, 8, 9 and from the cell surface. 10 This can then result in DNA collapse into a particle that promotes cell entry and is protected from extracellular and intracellular hazards.
Cell binding
It was originally thought that cationic amphiphile-DNA complexes entered cells by fusion with the plasma membrane. 11 Studies on cell entry and intracellular trafficking now show that just about all nonviral vectors enter cells through some type of endocytic pathway. 12 Even vectors thought to bind cells 'nonspecifically' have been shown to interact with certain types of exposed cell membrane components. Nonviral vectors may bind to cells through one or both of two types of cell binding interactions: receptor and nonreceptor binding.
Receptor binding
Early nonviral methods of gene transfer employed nonspecific mechanisms of general DNA complex precipitation onto cells, which appeared to be sufficient for nonspecific endocytic uptake by most cells. 13, 14 Later, cationic lipids able to engulf DNA could facilitate interaction with the plasma membrane, and entry of the DNA into the cell. 11, 15 These gene transfer methods can be efficient in many cell types in vitro, but a therapeutic potential in vivo required additional features of improved delivery. Nonspecific uptake in vivo, even if the plasmid contained cell-specific gene promoters, would require high, and potentially toxic, vector doses in order to systemically deliver a gene to a target tissue. 16 Adding cell-specific ligands or antibodies to gene transfer vectors potentially alleviates this problem by permitting lower and safer vector doses while facilitating tissue targeting.
In one of the earliest targeted vectors, asialoorosomucoid (ASOR) was chemically coupled to polylysine, which directed gene transfer to asialoglycoprotein receptors on hepatocytes in vitro and in vivo. 17, 18 Competitive inhibition of hepatocyte gene expression by free asialoglycoprotein demonstrated that the vector was target-specific. Similar results were found using transferrin (Tf) as a targeting ligand. 19 In each case, the vector facilitated DNA entry into the target cells by receptor-mediated endocytosis. However, as we will highlight later, an inability to escape the cellular endosome encapsulating each vector after endocytosis ultimately resulted in less than desirable levels of gene transfer. 20 Other ligands have since been tested for receptortargeted gene transfer. Ligand choice is largely dictated by whether or not the target receptor undergoes endocytosis. Among the additional ligands that have been tested are TGFa, 21 insulin, 22, 23 folate, [24] [25] [26] basic FGF, 27 integrin-binding motifs, [28] [29] [30] and heregulin. 31 Antibodies generated against certain cell-specific receptors also have been used to direct gene transfer. Antibody-directed molecular conjugates have been targeted to: CD3, [32] [33] [34] [35] CD5, 36 EGF-R, 37, 38 and ErbB2. 39 Key to the efficacy of an antibody-directed molecular conjugate, however, is the ability of the antibody to trigger receptor internalization. Other such target receptors have been: Tf receptor, 40, 41 ErbB receptor, 31, 42 folate receptor, 24 and integrins. 28, 29, 43 While ligand choice depends on the receptor being targeted, an additional consideration for targeting is the type of cell entry pathway that will be induced after ligation. As discussed later, the endocytic pathway used by the vector can depend on the targeting ligand and cell type.
Nonreceptor binding
The 'lock-and-key' fit of receptor-ligand interactions is largely defined by the protein structure of the interacting partners. For ligand-directed complexes, this interaction brings an extracellular vector to specific sites at the cell surface. An alternative cell surface interaction, however, is the electrophilic attraction between vector cations and highly anionic cell surface proteoglycans. Sulfated proteoglycans consist of a core protein covalently linked to one or more sulfated glycosaminoglycans. 44 These highly anionic chains, which are among the most negatively charged components of the cell, are likely targets of nonviral assemblies carrying a net positive charge. Thus, by careful formulation of vector assembly, a positively charged complex may enable transfection through binding to these negatively charged moieties. Verifying that complexes interact with proteoglycans can be achieved through competitive inhibition with free proteoglycans, pretreatment with proteoglycan cleavage enzymes, or comparing transfection in proteoglycandeficient cells, as illustrated in the following examples.
Polyplexes. The positive charges of cationic polymers such as polylysine can mediate vector binding to proteoglycans. Mislick and Baldeschwieler 45 showed that an excess of polylysine titrated against plasmid DNA, at an amine/nucleotide (+/À) charge ratio 41, produced optimal gene transfer and expression, while a charge ratio o1 yielded very little gene expression, in HeLa cells. The role of proteoglycans in transfection was examined by observing transfection efficiency after treatment with several glycosaminoglycan inhibitors. Treatment of cells with sodium chlorate, which prevents glycosaminoglycan sulfation, 46 inhibited transfection in a dose-dependent manner, reducing gene expression up to 70% compared to untreated cells. Heparin and heparan sulfate nearly completely abolished gene expression, whereas other free glycosaminoglycans either had no effect (chondroitan A and C, and hyaluronic acid), or partially reduced gene expression (chondroitan sulfate B). Moreover, treatment with the glycosaminoglycan lyases, heparinase II, and chondroitinase ABC, reduced gene expression by 78 and 20%, respectively. Finally, proteoglycan-deficient cells could not be transfected. This study implicated heparin/heparan sulfate proteoglycans as mediating transfection.
Lipoplexes. Cationic lipids may also transfect cells by way of proteoglycan binding. Mounkes et al 47 demonstrated that Raji cells, which do not express proteoglycans, could not be transfected by cationic liposome-DNA complexes unless the cells were stably expressing the proteoglycan, syndecan-1. Importantly, transfection efficiency by the complexes depended on a net positive complex charge. Transfection was blocked by pretreatment with sulfated polysaccharides, fucoidan, heparin, or dextran sulfate. These studies were expanded in vivo 51 and enter these cells through a heparin-inhibited pathway, implicating heparan sulfate glycosaminoglycans as contributing to binding. Moreover, complexes known as 'dodecahedrons', assembled from Ad3 penton base proteins, also bind and enter CHO cells by proteoglycan interaction. 52 Studies on adenovirus infection have already identified the Coxsackievirus Adenovirus Receptor (CAR) 53 and integrins, 54 respectively, as being the target receptors for each protein. It is likely, however, that proteoglycans act as either coreceptors 55 or alternative receptors for these viral capsid proteins.
Cell entry pathways
Macromolecules can enter cells through a number of different routes, including phagocytosis, macropinocytosis, clathrin-mediated endocytosis, caveolaemediated endocytosis, and nonclathrin-and noncaveolae-mediated endocytosis. Not all of these pathways have been completely characterized or understood to date. In this discussion, the major pathways identified as facilitating the uptake of numerous types of nonviral vectors to date are clathrin-mediated, caveolae-mediated, and macropinocytic routes.
Clathrin-mediated endocytosis
The majority of receptor-ligand complexes enter cells by clathrin-mediated endocytosis. 56 Receptor binding typically triggers the localized accumulation of clathrin structures on the cytoplasmic surface of the plasma membrane as it begins to invaginate, forming clathrincoated pits (Figure 1 ). The coat is composed of clathrin heavy and light chains that assemble into three-legged triskelions and associate with adaptor proteins (APs). The AP complexes, AP1 and AP2, identify with either the trans Golgi network (TGN) or plasma membrane, respectively. While the process of coated pit formation can be inhibited by potassium (K + ) depletion 57 or chlorpromazine, 58 more specific inhibition can be obtained using a dominant-negative mutant of Eps15, which normally docks AP2 to the plasma membrane 59, 60 or siRNA inhibition of clathrin heavy chain or a-adaptin production 61 ( Figure 1 ). As the coated pit continues to invaginate, it is pinched off into vesicles through the action of the GTPase, dynamin 62, 63 in a process facilitated by a number of different effector proteins. 64 The vesicles are then uncoated by a 70-kDa ATP-dependent enzyme. 65 The vesicle cargo is delivered rapidly to early (or sorting) endosomes that become acidified by ATP-dependent proton pumps 66 ( Figure 1) . In CHO cells, the pH of the early endosome is B6.0. 67 These endosomes traffic to either the lysosome, where the cargo gets degraded by lysosomal enzymes, or to recycling endosomes, where the cargo may recycle back to the cell surface. If the vesicular cargo is destined for the lysosome, the endosome becomes more acidified and matures to a late endosome (pH B5.0-6.0), as proton pumps transport hydrogen ions into the vesicle lumen 68 ( Figure 1 ). Certain drugs, such as bafilomycin A1, inhibit the vacuolar Figure 1 Clathrin-mediated endocytosis. Schematic shows endocytosis of receptor-ligand pairs and trafficking through either a degradative pathway (leading to lysosomes) or recycling pathway (leading to the recycling compartment and back to the cell surface). Items in red italics delineate inhibitors of the particular function indicated.
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ATPase that drives these proton pumps, thus preventing vesicle acidification. 69, 70 Eventually, the late endosome merges with the lysosome (pH 5.0-5.5), transferring its contents for degradation by lysosomal enzymes. Vectors internalizing through this pathway must avoid lysosomal degradation by incorporating mechanisms of endosomal escape. 12 To accomplish this, acid-triggered membrane penetration moieties have been incorporated into many types of nonviral vectors. 71 An example of a ligand that stimulates the receptor recycling pathway is Tf, which has been incorporated into several different nonviral vectors for targeting to the Tf receptor. 72 The Tf receptor undergoes clathrinmediated endocytosis and may enter two types of trafficking pathways. 73 In the first pathway, the receptor undergoes rapid recycling from early endosomes to the cell surface, within 10 min after uptake. In the second pathway, the receptor undergoes slow recycling to the cell surface from the recycling compartment, which is an organelle that recycling endosomes enter or exit 56, 74 ( Figure 1) . In CHO cells, Tf receptors recycle rapidly back from early endosomes to the cell surface with a half time of B10 min. 75 Both early endosomes and the recycling compartment are slightly acidic. To avoid recycling back to the cell surface, vectors utilizing this pathway must incorporate a mechanism of release from either organelle.
Caveolae-mediated endocytosis
Caveolae are flask-shaped invaginations in the plasma membrane enriched in cholesterol and sphingolipids, and marked by the integral membrane protein, caveolin. Caveolae internalize large molecular complexes, toxins, bacteria, and some viruses. 76 This pathway is of considerable interest in particular for molecular conjugates containing pathogen-derived trafficking peptides, since many pathogens (SV40 and cholera toxin included) are thought to use the caveolar pathway to evade degradation in the lysosomes. 77 Using different sized microspheres, Rejman et al 78 showed that molecular size can dictate whether cell entry occurs by clathrin or caveolae-mediated endocytosis. Microspheres of 200 nm in diameter or less entered cells through clathrin-coated pits by a microtubule dependent pathway. Uptake was rapid, inhibited by chlorpromazine, and microspheres eventually arrived at lysosomes. In contrast, microspheres with a diameter of 500 nm underwent slow, microtubule-independent uptake that was inhibited by amiloride and cytochalasin D. As discussed later, this finding might suggest that 500 nm microspheres enter cells by macropinocytosis, which accompanies membrane ruffling. However, membrane ruffling was not observed in this study. Uptake of 500 nm microspheres was not affected by K + depletion, chlorpromazine or the dominant-negative Eps15 mutant (all inhibitors of clathrin-dependent uptake), and the microspheres did not colocalize with lysosomes. Filipin, an inhibitor of caveolae-mediated uptake, blocked internalization of 450% of the 500 nm microspheres and only 20% of the 200 nm microspheres. Another inhibitor of caveolae-mediated uptake, genistein, blocked internalization of 450% of 500 nm microspheres whereas 200 nm microspheres were unaffected. As caveolae are typically sized from 55 to 65 nm, 77 this inhibitory effect of anticaveolar agents on large particle uptake was somewhat surprising.
Mundy et al 79 showed that caveolae were retained on the cell surface by cortical actin filaments (Figure 2 ). Disruption of actin by lantrunculin A facilitated the pinching off and internalization of caveolar vesicles, or 'cavicles', which then trafficked along microtubules to pericentrisomal caveosomes. 80 These caveosomes cluster near the microtubule organizing center (MTOC), in close proximity to recycling endosomes ( Figure 2) . Thus, the disruption of actin filaments actually enhances the inward movement of cavicles from the plasma membrane.
Targeting caveolae may enhance gene transfer across the endothelium in vivo. A monoclonal antibody specific for lung caveolae, TX3.833, could target lung endothelium in vivo after pulmonary artery perfusion, follow a transendothelial route, as observed by electron microscope (EM), and within 10 min, exit from caveolae into the subendothelial space. 81 Conjugating the antibody to a drug concentrated the drug to the lung when delivered systemically in vivo. As the endothelium presents a major barrier to systemically targeted in vivo gene transfer, the transcytosis ability of this antibody suggests that targeting the caveolar pathway may enhance vector delivery to desired tissue.
82,83

Macropinocytosis
Macropinosomes are formed by actin-driven ruffling of the plasma membrane, followed by folding and pinching off of irregular sized vesicles 84 ( Figure 2 ). Membrane ruffling is nonclathrin-mediated and inhibited by cytochalasin D, which disrupts actin filaments. Relatively large macromolecules enter cells through either macropinosomes or phagosomes, whereas small molecules (as described earlier) typically enter by clathrin-, caveolarmediated processes, or micropinocytosis. Macropinocytosis is inhibited by amiloride, which blocks the Na + /H + exchanger and inhibits ruffling 85, 86 ( Figure 2 ). Macropinocytosis is also dependent on PI3K and Rho GTPase activities, which regulate actin reorganization. While PI3K inhibitors, such as wortmannin and LY294002, 87, 88 Figure 2 Nonclathrin-mediated endocytosis. Macropinocytosis and caveolar endocytosis are shown. Items in red italics delineate inhibitors of the particular function indicated.
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and Rho GTPase inhibitors, such as toxin B, 89 can inhibit macropinocytosis, they affect other endocytic pathways as well. Macropinosomes can acidify but do not intersect with lysosomes, 90 thus representing a potential alternative cell entry route of gene transfer for the avoidance of lysosomal degradation. Studies on Ad-host interactions found that cytosolic release of macropinosomal contents may be triggered by receptor signaling. 91 While other types of cell entry pathways exist, some of which are little understood, those just described earlier have been identified as largely contributing to the uptake of numerous types of nonviral vectors. To delineate these cell entry pathways for the uptake of a particular vector, trafficking inhibitors, in addition to trafficking markers and special cell lines, can be used. However, very few endocytic inhibitors are specific to one pathway, thus it is often necessary to implement several different types of inhibition to determine the contribution of a cell entry pathway to nonviral uptake. It is often the case, as shown in the following examples, that multiple pathways contribute to the uptake of a particular vector, although one main route may account for the majority of vector cell entry.
Lipoplexes. While several drugs that can inhibit both clathrin-and caveolae-mediated pathways of cell entry reduce transfection by SAINT-2/DOPE liposomes, HepG2 cells lack caveolae, thus implicating a clathrinmediated route in these cells. 92 Transfection by these lipoplexes could be substantially reduced by cholesterol depletion with methyl-b-cyclodextrin (MbCD) or chlorpromazine, while an inhibitor of caveolae-mediated endocytosis, 93 filipin III, blocked transfection by 20%. Localization of the lipoplexes with Tf receptor, used as a marker for clathrin-coated endosomes, 94 and inhibition of internalization by dominant-negative Eps15, and K + depletion, which both arrest coated pit formation, confirmed a clathrin-mediated route of uptake. Using LysoTracker s red, which labels acidic compartments, it was shown that these lipoplexes eventually ended up in lysosomes, 95 in consistency with a pathway linking clathrin-dependent cell entry to lysosomal targeting. 56 Polyplexes. Superparamagnetic iron oxide coated with PEI, or magnetofectins, transfect cells by application of a magnetic field. 96 EM imaging studies and inhibition of cell entry by multiple inhibitors led the authors to conclude that magnetofectins entered cells through both clathrin-and caveolae-mediated pathways. Endocytic cell entry was inhibited by nystatin, which blocks caveolae formation, 97, 98 and antimycin A, which generally depletes ATP, indicating that uptake occurred by energy-dependent endocytosis. Transfection was also inhibited by chloroquine, suggesting that complexes were trapped in early endosomes, and required acidification to facilitate endosomal release. Colchicines and nocodazole also reduced gene transfer, indicating that intact microtubules are required for transfection. EM imaging showed complexes internalizing into both clathrin coated and caveolar vesicles. Cell entry through both clathrin-dependent and -independent pathways was also observed using histidinylated polyplexes. 99 Importantly, however, clathrin-dependent endocytosis supported efficient transfection, while macropinocytosis actually inhibited efficient transfection in HepG2 cells.
As these polyplexes presumably penetrate into the cytosol in response to endosome acidification, the authors speculated that the lumen of macropinosomes is not acidic enough to induce histidine-mediated membrane disruption. Thus, while macropinosomes may avoid intersection with lysosomes, and enable escape from lysosomal degradation, these vesicles may ultimately represent a potential intracellular dead-end to gene transfer.
Targeted lipopolyplexes. A ligand which normally
induces receptor-mediated endocytosis into clathrincoated pits and vesicles should likewise induce the same when incorporated into a gene transfer complex, and indeed this is the case for an integrin-targeted lipopolyplex. 100 An Arg-Gly-Asp (RGD) targeted vector appeared to enter into clathrin-coated pits and vesicles, as visualized by EM, and uptake was inhibited by K + depletion. Uptake was also inhibited with hypertonic medium, which renders clathrin unavailable for assembly. 101 Trafficking was affected by the phosphatidylinositol-3-OH kinase (PI3K) inhibitors, wortmannin and LY294002, as PI3K contributes to vesicle fusion. 102 Cytochalasin B, which inhibits F-actin assembly, slightly increased uptake. Cytochalasin B blocks noncoated pit formation and phagocytosis but not clathrin-mediated endocytosis.
103, 104 Although not addressed in this study, these findings might suggest that a certain proportion of targeted lipoplexes become trapped in caveolae, which may be retained at the cell surface by intact actin. Enhanced lipopolyplex uptake from actin disruption would support this.
In contrast to the example just described, a study by Simoes et al 48 showed that Tf-targeted lipoplexes may still enter cells by nonreceptor endocytosis. Transfection by these complexes was inhibited very little by free Tf. Gene transfer was inhibited by cytochalasin B, used to inhibit phagocytosis and pinocytosis, but not receptormediated clathrin-dependent endocytosis. Apparently, the size of the complex matters, as 500 nm complexes entered cells through noncoated vesicles, but not through coated vesicles, which have been reported to be 80-100 nm in diameter. 92 Importantly, complexes of this size, while able to enter cells, yielded relatively low levels of gene transfer and expression, suggesting that clathrincoated endocytosis is linked to endosomolytic ability.
Molecular conjugates.
A fragment from the human immunodeficiency virus (HIV) viral protein R (Vpr) can bind nucleic acid and mediate nonviral gene transfer. 105 A study on the cell entry pathway of Vpr-DNA complexes showed that the vector entered cells via endocytosis, 106 although full-length Vpr is usually packaged inside the viral capsid and does not normally contribute to viral infection. Cytochalasin B or amiloride did not inhibit vector uptake, thus ruling out phagocytic or macropinocytic endocytosis. Uptake was inhibited 100-fold by cholesterol depletion using MbCD, which affects both clathrin and caveolae-mediated endocytosis. 94 MbCD treatment of HepG2 cells, which lack caveolae 107 also reduced uptake 100-fold, suggesting that these complexes enter these cells by clathrinmediated endocytosis. It is unclear from these studies, however, as to the identity of the cell surface receptor that may mediate cell entry of these complexes.
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Transcriptional activators, such as the HIV transactivator of transcription (TAT) and Drosophila antennapedia (Antp) proteins, contain basic domains that have been the center of controversial studies regarding an ability to translocate across cell membranes. 108 This function appeared to be imparted by the presence of arginines in the peptides, and could be mimicked by synthetic polyarginine oligopeptides. 109 These basic protein transduction domains (PTDs) have been fused to various cargo to facilitate their cell entry and intracellular trafficking, although the actual mechanism of transduction had been unknown for some time. Recent studies have indicated that the mode of cell entry is endocytic, 110 likely via the binding to and internalization of cell surface proteoglycans. [111] [112] [113] In agreement, cell entry of a nonaarginine peptide (R9) was found to be proteoglycan-mediated, as R9 was not taken up by proteoglycan-deficient CHO cells, and cell binding and entry was also inhibited by heparin. 114 Several studies have identified macropinocytosis as being the major cell entry route of TAT PTD peptides, and similar proteins, that bind proteoglycans. Studies on the trafficking of protein fusions to the TAT PTD suggest that this pathway is temperature, and energy-independent, as TAT-fusions accumulated in cell surface patches by a temperature-independent mechanism, followed by temperature-dependent internalization. 115 Whereas some reports of temperature-independent uptake by PTDs have been explained as an artifact of cell fixation, 110 it is possible that these temperature-independent accumulations are indicative of cellular phenomena associated with macropinocytosis, such as the membrane ruffling that precedes macropinosome formation. Moreover, others reports suggest that macropinosomes are inherently leaky, 91, 116 thus cytosolic entry through these large vesicles is a possibility. In agreement, we have observed large vesicles resembling macropinosomes during the temperature-independent, heparin-sensitive uptake of recombinant Ad5 fiber protein by HeLa cells. 117 Consistent with a macropinocytic route, fiber uptake and intracellular trafficking required intact actin. With regard to TAT-fusion uptake, membrane ruffling inhibitors amiloride and cytochalasin D blocked cell entry, as did cholesterol depletion using MbCD, and cholesterol sequestration using nystatin. 115 Importantly, whereas both types of inhibition delineate macropinocytic and caveolar routes of endocytosis, the reporter T cell line used in these studies lacked caveolin expression.
As with many vectors, cell type and the availability of certain cell entry molecules ultimately dictate the uptake pathway of TAT or TAT-derived proteins. As an example, and in contrast to the previous examples, caveolae are partially utilized for the uptake of bacteriophage l expressing a TAT PTD peptide on the particle surface for entry into COS-1 cells. 118 While wild-type phage do not typically infect mammalian cells, it is possible that the context of the phage may influence entry into caveolae, although it is shown elsewhere that TAT fusion proteins alone also use caveolae to enter HeLa cells. 119 Using FACS analysis of live cells, Silhol et al 112 showed that the TAT basic domain entered proteoglycan-deficient CHO cells though the actual route of uptake was not identified. Transfection of A549 cells by lipoplexes (DOTAP or Lipofectin) decorated with TAT PTD, used here to presumably facilitate cytosolic entry, was inhibited by 41C but enhanced by chloroquine, 120 suggesting that an endocytic, possibly clathrin-mediated, pathway enabled uptake. While not indicated in this study, elsewhere clathrin-dependent uptake is implicated in transfection by lipoplexes alone, 121, 122 although in each of these studies, a specific cell surface receptor is not identified as mediating cell entry. In comparison, fulllength TAT enters T cells via clathrin-coated pits and endosomes after binding cell surface receptors utilized by HIV for infection. 123 In contrast, CHO cells, which lack T-cell-specific receptors, take up full-length TAT via proteoglycans. 113 Clearly
Endosomolysis
The cellular endosome is a major barrier to efficient gene transfer. Receptor endocytosis into clathrin-coated vesicles enables the cell entry of many ligands, including viruses, 56 but the cargo is usually transported to lysosomes where it is degraded by lysosomal proteases. Endocytosis into noncoated vesicles may avoid lysosomes, but likely leads to entrapment in endosomes. Thus, an endosome escape mechanism is a necessary feature of nonviral complexes, especially targeted vectors. 25 Early targeted vectors underwent high uptake, but low gene expression because they lacked an endosomolytic feature. 124 The requirement for chloroquine or glycerol to enhance gene expression suggested that these vectors were trapped in endosomes after cell entry. Such agents interfere with lysosomal degradation by preventing endosome acidification and enhancing membrane permeabilization.
Studies on mechanisms of endosomal membrane penetration, including those borrowed from naturally evolved biological systems, have aided the design of improved nonviral vectors with enhanced gene transfer due to endosomolytic factors. From these studies, several different mechanisms of endosomolysis have been proposed.
Pore formation Molecular conjugates. The diptheria toxin (DT) translocation domain undergoes a conformational change at pHo5.5 and inserts into the endosomal membrane, forming ion channels. 125 Its membrane lytic activity was demonstrated by its ability to permeabilize vesicles under acidic conditions and release entrapped contents. 126 When chemically coupled to polylysine and incorporated with an ASOR-targeted complex, gene transfer was enhanced in a manner dose-dependent to the DT conjugate, implicating endosomal penetration as the means of enhancement. 127 The DT domain could also be expressed as a single fusion protein flanked by a Gal4 128 Gene transfer by this conjugate was reduced 70-90% by bafilomycin A 1 , ammonium chloride, methylamine, or nigericin, indicating that endosome acidification was required for efficient transfection.
Melittin, a major component of bee venom, is a 26 amino-acid cationic peptide with membrane penetration properties. Melittin forms an amphipathic a-helix in aqueous solution and interacts with lipid membranes through a positively charged cluster (KRKR). The mechanism by which melittin inserts into the membrane and disrupts it has been vigorously studied, and evidence supports a model in which it forms toroidal pores 129, 130 (Figure 3a ). In this model, the peptides induce perturbations in the membrane and bend it so that the top and bottom layers of the bilayer join contiguously at the pore wall. Melittin incorporated into PEI complexes improved gene transfer up to 700-fold for luciferase reporter gene delivery, and up to 20-fold for delivery of pEGFP. 131 Labeled PEI-DNA complexes were found in vesicle-like accumulations in live cells, whereas melittin-PEI-DNA complexes appeared more diffuse, suggesting endosomal escape occurred by 4 h after uptake. This was supported by an assay indicating that the fluid phase marker, FITC-dextran, was trapped in acidified vesicles with PEI-DNA but found in a neutral environment, such as the cytoplasm, with melittin added.
Another pore-forming peptide, GALA, is mainly comprised of a Glu-Ala-Leu-Ala repeat, designed to mimic the membrane penetrating activity of viruses. 132 GALA undergoes a conformational change from a random coil at neutral pH to an amphipathic alpha helix at acidic pH, 133 promoting high membrane binding. GALA peptides can aggegrate and accumulate within the cell membrane until, at a certain threshold, pores are formed. 134 GALA enhanced cytosolic release of a fluid phase marker cointernalized with Tf-targeted liposomes compared to complexes lacking GALA. 135 While these particular studies did not examine DNA delivery by these complexes, they demonstrate that modified GALA, synthesized to attach to the surface of liposomes, undergoes pH-dependent conformational changes consistent with a-helix formation, and induces membrane fusion.
The ability for GALA to enhance gene transfer was demonstrated by its chemical conjugation to dendrimers. 136 Importantly, this study demonstrated that endosomolytic activity of GALA is not lost upon modification by covalent linkage. However, to avoid potential complications arising from chemical bond formation, one group demonstrated that a similar endosomolytic peptide, JTS-1, could noncovalently incorporate into DNA complexes via electrostatic interaction with the net positive charges resulting from an excess of the lysine-rich DNA condensing peptide, K8. 137 In that study, JTS-1 enhanced gene transfer, presumably through endosomolysis. As a different approach, vector assembly was further streamlined by incorporating both DNA binding and membrane destabilizing activities into a single GALA-like peptide. 138 This was accomplished by replacing the glutamates within the GALA repeat sequence with lysines, forming the peptide analogue, KALA. Like GALA, this peptide formed an amphipathic a-helix, with the lysines in alignment on one face of the helix. However, KALA switched to a mixture of a-helix and random coil conformations in response to a reduced pH. Moreover, membrane destabilization was not pH dependent, and apparently occurred over a wide pH range, likely due to the strong electrophilic interactions between the positive charges on KALA and negatively charged membranes. In contrast, another cyclic amphipathic peptide, gramicidin S, also condenses DNA, and, when combined with a DNA/DOPE complex, enables gene transfer by an apparently pH independent mechanism. 139 While JTS-1, KALA, and gramicidin S all apparently enhance gene transfer, presumably by inducing endosomolysis, it remains unclear as to whether these peptides form pores or disrupt membranes via mechanisms similar to GALA and melittin. Pore formation by both GALA and melittin peptides, on the other hand, may accelerate an additional mechanism of membrane penetration by phospholipid 'flip-flop', as described next. 140 Fusion and/or flip-flop Lipoplexes. Fusion of liposomes and endosomal membranes is thought to be one way of enabling endosome escape of lipoplexes. Cationic lipid induced fusion between liposomes could be demonstrated by a reduction in fluorescence resonance energy transfer (FRET) activity detected from the escape and transfer of entrapped fluorophores between joined liposomes. 141 While this effect was tested using histidylated cationic lipids, it is unclear from these studies whether the single histidine grafted onto the lipid complexes has any bearing on endosomolytic ability, though enhanced gene expression over FuGENE(TM)6 and DC-Chol in certain cell types was observed. Importantly, the reduction in FRET activity was observed at low, but not neutral, pH, supporting an acid-induced mechanism of endosome escape by these lipids. Whether this mechanism is utilized for endosomolysis and DNA release by the lipoplex, however, remains to be seen.
The neutral phospholipid dioleoylphosphatidylethanolamine (DOPE) is likely to impart the fusogenic activity when incorporated into lipoplexes. Most types of cationic lipids require a phospholipid for stabilization in a lipid membrane bilayer; however, the type of phospholipid is apparently critical for transfection. DOPE, which contains an ethanolamine head group, promotes transfection whereas a similar neutral phospholipid, dioleoylphosphatidylcholine (DOPC), which contains a choline head group, does not. 142, 143 A critical factor accounting for this difference in transfection enhancing activity is that DOPE forms nonbilayer lipid structures whereas DOPC does not (Litzinger D and Huang. Biochim Biophys Acta 1992; 1113: 201). Moreover, electron microscopy has shown that DOPE-containing lipoplexes destabilize endosomes whereas DOPC-containing lipoplexes do not.
121 DOPE-containing lipolexes can transition from bilayer to inverted hexagonal structures, 144, 145 which, due to their instability, rapidly fuse to anionic vesicles and release DNA.
A mechanism of lipoplex fusion and DNA release into the cytoplasm was proposed by Xu and Szoka, 146 based on the established ability of membrane phospholipids to flip to apposing membrane bilayer leaflets. In this model, the endosomal membrane encompassing a cationic lipoplex becomes destabilized by the complex, thus enabling anionic lipids facing the cytoplasmic side of the membrane 147 to flip and face the endosomal lumen (Figure 3b ). These anionic lipids mix with cationic lipids comprising the liposome, laterally diffusing into the complex and forming charge neutral ion pairs with the complex lipids. This process displaces the DNA from the cationic lipids, and releases the DNA into the cytoplasm. The ability of anionic lipids to release DNA from lipoplexes supported this model. However, speculations based on the theoretical number of anionic lipids in a given endosome of 150 nm diameter find it unlikely that a sufficient number would be present to displace and release an endocytosed plasmid molecule. 148 On the other hand, evidence supports this model as a mechanism of oligonucleotide release from endocytosed lipoplexes. 149 Under normal conditions, phospholipid flipping is necessary to maintain lipid asymmetry in the membrane, and is catalyzed by flippase enzymes. 150 Channel forming antibiotics, such as amphotericin B, 151 can enhance phospholipid flipping. Pore-forming peptides, such as GALA and melittin, may also induce flip-flop of phospholipids within the vicinity of the pore. 140 The proposed mechanism, based on observations after GALA is added to asymmetrically labeled vesicles, suggests that the phospholipid head group resides in the pore lumen while the acyl chains remain within the hydrocarbon interior of the bilayer before exchange to the apposing bilayer leaflet. Amino-acid composition of the peptides lining the pore may influence the rate of flip-flop, depending on the net charge of the peptides.
Proton sponge Polyplexes. Endosomal disruption by a 'protonsponge' mechanism has been attributed to polyamidoamine (PAM) 136 and PEI, 3 based on the titratable amines incorporated into these branched polymers. For example, every third atom of PEI is an amino nitrogen that can be protonated during endosome acidification, thus imparting a high buffering capacity over nearly the entire pH range. Massive proton accumulation invokes high chloride ion influx into the endosome, causing osmotic swelling of the endosome and eventual vesicle lysis (Figure 3c ). Blocking vacuolar proton pumps by inhibitors such as bafilomycin A 1 prevents PEI transfection in a Intracellular trafficking of nonviral vectors LK Medina-Kauwe et al cell type-specific manner. 152 Evidence for Cl À accumulation and pH decrease induced by PEI and PAM was shown by using Cl À and pH indicators during polyplex uptake in CHO-K1 cells. 153 In this study, an increase in the volume of polyplex-containing vesicles was observed, followed by dissipation of fluorescentlytagged polyplexes, indicative of vesicle swelling and disruption. While the authors suggest that the polyplexes enter 'macropinocytic' endosomes, it is unclear whether these vesicles are indeed macropinosomes, as it has not been established whether these vesicles acidify or associate with vacuolar proton pumps.
Other mechanisms
The previous examples support defined mechanisms of endosomolysis, but vesicle penetration is not limited to these alone. Numerous vectors are known to destabilize the endosomal membrane through mechanisms that likely differ from the ones described previously, but have yet to be firmly characterized.
Polyplexes. Histidylated polymers are thought to escape endosomes through a combination of membrane disruption and proton-sponge effects caused by imidazole protonation during endosome acidification. 154 Polylysines partially substituted with histidyl residues transfect cells in the absence of endosome disrupting agents, and through a mechanism inhibited by bafilomycin A1. 155 Amphipathic cationic polymers containing strategically placed histidine residues disrupt bacterial and mammalian cell membranes in response to acidic pH, and promoted gene transfer to several cell lines at levels comparable to 25-kDa PEI. 156 The transfection efficiency of histidine-rich peptides depends on the number and positioning of histidine residues. 156 The amphipathic histidylated peptide, LAH4, and related derivatives, contain lysines at each end and form a-helices in the presence of membranes, with the histidines in alignment on one face of the helix. 157 These peptides interact with membranes and assume a transmembrane orientation at physiological pH, but switch to a in-plane orientation at pHo6, 158 promoting membrane disruption. This mechanism likely accounts for the antibiotic activity of these peptides as well. 157 Molecular conjugates. Many molecular conjugates have incorporated within them cell penetration peptides or proteins derived from pathogens. Fusogenic peptides derived from the influenza virus HA2 protein have been incorporated into nonviral vectors to facilitate endosome escape. 71 During virus infection, the fusion peptide, comprising the amino-terminal region of HA2, is normally buried within the HA trimer. 159 A drop in endosomal pH provokes conformational rearrangements that extrude the fusion peptide from its buried location 160 to interact with the target membrane and induce fusion with the virus membrane. Membrane fusion by mutant HA2 peptides and synthetic analogs have been tested by lysis of erythrocyte membranes and the production of heterokaryons in HA2-expressing cells. 161 When incorporated into an ASOR-targeted gene delivery polymer, the HA2 peptide enhanced gene transfer to the liver 300-fold higher than complexes lacking the HA2 peptide. 162 The authors reported observations that the peptide induced diffusion of the complex into the cytoplasm, suggesting that gene transfer enhancement was due to HA2-induced endosomolysis.
The endosomal lytic activity of the adenovirus is attributed to the penton base capsid protein, as studies show that the penton base undergoes a conformational change at low pH, exposing hydrophobic regions that bind nonionic detergents. 163 Under acidic conditions, the penton base binds selectively to a v b 5 integrins, which mediate membrane penetration and support two-to four-fold higher levels of Ad gene transfer than a v b 3 . 164, 165 The membrane penetration activity appears to depend on a TVD motif in the cytoplasmic domain of the b 5 subunit. 164 While the exact mechanism of membrane penetration remains unclear, the endosome escape function that the penton base imparts has attracted the development of several types of penton-based nonviral vectors derived from Ad3, 166 Ad5, 43 and Ad7. 167 The penton base fusion protein, HerPBK10, targeted gene transfer to heregulin receptors and required the penton base domain to retain high levels of gene transfer. 31 Lack of the penton base domain nearly completely inhibited gene transfer. The inability of chloroquine to enhance gene transfer further suggested that the complexes escaped lysosomes, though an actual mechanism of penton base-induced membrane lysis remains to be seen.
A study comparing rhinovirus (HRV2) and adenovirus membrane penetration suggested that the type of endosomolysis induced by adenovirus penton base is characterized by a broad disruption of the membrane whereas the HRV2 VP1 protein induces pores of a distinct size. 168 Peptides derived from both HRV2 VP1 and influenza virus HA proteins allowed escape of low molecular weight (MW) (ie 10 kilodaltons, or kDa), but not high MW (ie 70 kDa), dextrans from endosomal vesicles. Likewise, whole HRV2 enabled endosome leakage of only the 10 kDa, but not the 70 kDa, molecule. In contrast, Ad serotype 5 (Ad5) stimulated release of both size molecules. In both cases, endosome leakage was dependent on vesicle acidification.
Cytosolic trafficking
For many nonviral vectors, it remains unclear whether the vector remains enclosed in vesicles during the majority of the intracellular transit toward the nucleus. If so, the type of vesicle may dictate the cytosolic trafficking behavior of the vector. If the vector escapes the vesicle, additional cytosolic hazards may await. These cytoskeletal and cytosolic factors, in addition to cell type, can influence cytosolic trafficking.
Cytoskeletal factors
The cytoskeleton provides a highway for the transport of vesicles and their encapsulated cargo from one organelle to another. 169 Typically, vesicle movement is mediated by molecular motors along particular cytoskeletal elements, and in particular directions in cells. Vesicles emerging from clathrin-mediated pathways, for example, translocate along microtubules via dynein motors, propelling the vesicles toward the microtubule minus end. 170 Numerous viruses have taken advantage of this intracellular transport system and utilize dynein-mediated trafficking to catch a ride to nuclear periphery. [171] [172] [173] [174] [175] [176] While in some cases intact cytoskeletal elements are Intracellular trafficking of nonviral vectors LK Medina-Kauwe et al required for appropriate nonviral vector trafficking in cells, in other cases, the cytoskeleton may either interfere with intracellular translocation or direct nonviral vectors to undesirable sites within the cell. In many of the studies mentioned earlier, the contribution of the cytoskeleton to vector uptake and vesicle trafficking was described. The following additional studies examine the role of the cytoskeleton in intracellular vector motility.
Lipoplexes. A study on lipoplex transfection has
shown that microtubule disruption can enhance gene transfer, presumably by preventing transit to lysosomes. 177 In this study, the microtubule disrupting drug, nocodazole, and the microtubule stabilizing drug, taxol, both increased transfection effiency. Nocodazole induced scattering and noncolocalization of liposomes and lysosomes, whereas taxol resulted in relocation of lysosomes only around the nucleus and noncolocalization with microtubules or liposomes. The initial uptake of the lipoplexes was not affected, in agreement with previous reports that initial endocytic uptake is actin, and not microtubule, mediated. 56, 178 In another study microtubule disassembly induced with nocodazole but not microtubule assembly induced with taxol increased intracellular accumulation of lipoplexes in parallel with transfection efficiency. 179 Wang and MacDonald 180 took these findings one step further by incorporating microtubule depolymerizing drugs into the lipoplex to enhance gene transfer. When incorporated into the lipoplex, gene transfer nearly doubled. However, when the drug was added simultaneously with the complex, there was no transfection enhancement, presumably because endosome sorting, which requires intact microtubules, and perhaps even endocytic invaginations, were impaired. 181 Thus, the drug was likely released after cell entry. Additional microtubule disrupting agents, including vinblastine (VB), colchicine, vincristine, nocodazole and podophyllotoxin, similarly enhanced gene transfer. These drugs likely prevented trafficking to lysosomes, as endosomes require intact microtubules to translocate from the plasma membrane to lysosomes. [181] [182] [183] [184] The authors speculated that microtubule depolymerization also activated the NF-kB transcription factor, thus inducing NF-kB-dependent gene expression, as described elsewhere. 185 Molecular conjugates. A study on transfection by recombinant polyoma virus coat proteins assembled with DNA observed that these complexes entered at least two pathways: one that was clathrin-mediated and microtubule dependent, leading to transfection, and another that was actin mediated and nonproductive for transfection. 186 Microtubule depolymerization by nocodazole nearly completely abolished gene transfer, whereas actin depolymerization by cytochalasin D did not. While two pathways of trafficking were observed, the bulk of material entering cells translocated by the actin-mediated route. Importantly, many of the complexes were reported to form large aggregates with up to micrometer diameters. As discussed earlier, it is likely that these complexes entered cells through an actindependent, possibly macropinocytic, pathway that has been implicated in the transport of large aggregates.
Actin-dependent trafficking of vectors or proteins may follow binding and entry through proteoglycans. We have found that the Ad5 fiber protein exhibited an unexpected ability to facilitate gene transfer of protamine-DNA complexes. 51 Transfection by the fibermediated complex, called FPO, required binding to the Ad5 receptor, CAR, but the receptor itself did not endocytose. As the fiber is not known to be the cell entry protein for Ad5 infection, its mode of uptake and trafficking without the virus was examined. Cell entry was temperature-independent and inhibited by actin disruption using cytochalasin D but not microtubule disruption using nocodazole. The fiber colocalized with actin filaments, as observed by confocal microscopy. Both cell binding and uptake was dose-dependently inhibited by heparin, suggesting that heparan sulfate proteoglycans acted as coreceptors for cell binding and endocytosis. The similarities of these findings with those of studies described earlier suggest a macropinocytic pathway of fiber cell entry.
Primary cells versus cell lines Molecular conjugates. Interestingly, very little information on the trafficking of molecular conjugates is available in primary cultures of terminally differentiated cells or organ models, although these situations may best approximate the situation in situ. Some recent studies in secretory epithelial cells of the lacrimal (tear) gland suggest that the ability of molecular conjugates to 'hijack' intracellular trafficking pathways in order to rapidly target the nucleus is dependent upon the cell type. For example, a recombinant Ad5 penton base protein, which has been incorporated into several types of molecular conjugates for its endosomolytic and intracellular trafficking capacity, efficiently internalized into intracellular sites in HeLa cells, 51, 187 but was observed at the surface of primary acinar epithelial cells even after 24 h of sustained incubation, with no evidence for penton internalization or recovery in cytoplasm or intracellular organelles. 188 In contrast, Ad5 efficiently entered these cells in a pattern consistent with endocytosis, 188 following the same general profile as shown in other systems. 189 The conclusion from this study was that recombinant penton is not internalized in this particular cell type. Thus, a molecular conjugate based on this particular capsid protein would likewise not be efficiently endocytosed nor able to exit the endosomes. This finding indicates the importance of evaluating the trafficking patterns of molecular conjugates in a variety of different cell and tissue models.
Another issue that is clear from studies on the intracellular trafficking of molecular conjugates is that the conjugates themselves have the ability to modulate other intracellular trafficking pathways. In secretory epithelial cells of the lacrimal gland, both intact Ad5 capsid and recombinant Ad5 penton base protein separately induced similar changes in the organization of the regulated secretory pathway and carbacholstimulated release of tear proteins. 190 Both elicited the depletion of rab3D-enriched mature secretory vesicles in the subapical cytoplasm, an effect that was not associated with altered rab3D expression nor its release from cellular membranes. A different Ad5 capsid protein (knob) at the same dose elicited no such effect, indicating Intracellular trafficking of nonviral vectors LK Medina-Kauwe et al that the penton base protein was sufficient to alter the organization and function of the lacrimal acinar secretory pathway. Moreover, competition studies showed that RGD peptide partially prevented the penton-induced changes in rab3D-enriched secretory vesicles, suggesting that penton-a v integrin interactions were involved in modulation of the acinar secretory pathway. 188 Signaling effects from surface-bound penton base mediated through a v integrins may therefore alter intracellular signaling pathways essential for maintenance of acinar secretory functions.
The example above illustrates the potential effects of a single molecular conjugate on an important cellular function, stimulated exocytosis in a secretory epithelial cell. It is important to remember, in the use of these powerful molecular conjugates, that these agents are adapted to 'hijack' endogenous trafficking machinery to promote viral or pathogen entry. This is well understood and appreciated for the use of nuclear targeting signals for instance, which are essential components of most molecular complexes, but considered to a lesser extent for other types of sorting signals that may modulate endosomal sorting and intracellular trafficking. Examples of sorting sequences in viral proteins considered in molecular conjugates that have the potential to interact with clathrin and adapter proteins include the dileucine, in the Ad5 penton base protein 187 and YXXL in the HIV-1 envelope glycoprotein. 191 The potential host cell toxicity associated with the interaction of viral capsid proteins with endogenous trafficking machinery and the consequent recruitment away from essential cellular pathways is an important area to consider in future research investigations on trafficking mechanisms of molecular conjugates.
Cytosolic degradation
Lechardeur et al 192 showed that naked DNA microinjected into the cytoplasm of HeLa and COS cells can become degraded by cytosolic nucleases. While coinjected TRITC-dextran spread throughout the cytosol, naked plasmid DNA progressively disappeared from the cytoplasm with a half-life of B90 min. Importantly, neutralization of acidic compartments, such as endosomes and lysosomes, by ammonium chloride or chloroquine did not affect DNA disappearance. Complexing the DNA with cationic lipids or polymers conferred resistance to cleavage, thus the charge neutralizing and DNA condensing activity of these agents can protect the DNA from intracellular nucleases. Pollard et al 193 attributed this cleavage activity to Ca 2+ -dependent nucleases present in the cytoplasm, but not the nucleus. Cleavage activity could be completely inhibited by endonuclease inhibitors, aurin tricarboxylic acid (ATA) and Zn 2+ , 194 but was insensitive to levels of Mg 2+ or Na + . Thus, release of DNA from carrier molecules in the cytoplasm could have a detrimental effect on gene transfer.
DNA size and mobility
Lukacs et al 195 demonstrated that the motility of DNA in the cytoplasm was dependent on DNA size. Doublestranded DNA fragments from 21 to 6000 bp in length were microinjected into the cytoplasm of HeLa cells. Whereas the 21-mer exhibited rapid diffusion and accumulation into the nucleus by 5 min after injection, the 6 kb DNA remained at the site of injection after 5 min. A 500 bp fragment distributed throughout the cytoplasm and reached, but did not enter, the nucleus. The mobilization of the small fragments has been attributed to interaction with nuclear proteins that enable transport into the nucleus. 196, 197 The immobility of the large fragments, however, is likely due to macromolecular crowding in the cytoplasm. Thus, decondensation of DNA in the cytoplasm not only increases the chances of degradation, as described earlier, but decreases its ability to move toward the nucleus.
Nuclear entry
As just described, small DNA fragments in the cytoplasm can readily accumulate in the nucleus, presumably by diffusion through the nuclear pore. The size of the nuclear pore complex (NPC) is B55 Å , or 25-30 nm, 198 in diameter and permits the passage of molecules with a MW of p40 kDa. 199 Larger molecules, however, require a mechanism of active transport in a quiescent cell.
Cellular and molecular determinants
Proteins destined for the nucleus typically contain a nuclear localization sequence (NLS). 200 This sequence is recognized by cytoplasmic proteins known as karyopherins or importins, which bind the motif and form a pore targeting complex. 200, 201 The complex docks at the NPC by interacting with fibrils protruding from the NPC cytoplasmic ring. Studies on the entry of viruses into the nucleus have also shown that viral capsids dock at pores. 202, 203 and interact with fibrils extending from the cytoplasmic face of the NPC. 204 Passage through the NPC is energy-dependent, and can be inhibited by the lectin wheat germ agglutinin (WGA), which binds to N-acetylglucosamine residues on NPC proteins. 205 It is thought that the NPC may undergo conformational changes in response to calcium levels that would enable passage through the pore. 206 Antibodies that block the NPC inhibit nuclear import of both Ad DNA and NLScontaining proteins. [207] [208] [209] Attempts to deliver naked plasmids into the nucleus have included incorporating the Simian Virus 40 (SV40) promoter and origin of replication into the DNA molecule to promote recognition by cellular NLS-containing proteins, such as transcription factors, that could bind to these cis-acting sequences. 210 However, it has been unclear whether such sequences are sufficient for nuclear transfer, and additional consideration on incorporating nuclear transport factors has led to the inclusion of different types of proteins or peptides to fulfill this role.
Lipoplexes. The need for nuclear targeting agents in lipoplex vector design was shown by Holmes et al, 211 who examined the intracellular distribution of DNA fragments after lipoplex delivery. Cystic fibrosis (CF) human airway epithelial cells were transfected with lipoplexes delivering radiolabeled 500 nucleotide (nt) single-stranded (ss) or double-stranded (ds) fragments. After cell fractionation, B7-8% of ss fragments were associated with the nuclear fraction, depending on the complex formulation. These findings were verified by confocal microscopy, which revealed diffuse fragment 197 observed that 60% of oligonucleotides delivered by DOTAP accumulate in the nuclei of CV-1 cells. Nuclear entry was independent of endosome acidification and microtubule polymerization, but required intact actin, thus the main cell entry pathway for these lipoplexes appeared to be via uncoated endosomes. While a flipflop mechanism of oligonucleotide release from endosomes was proposed as mediating vesicle escape, if these complexes entered cells via macropinosomes, as these results might suggest, the reported leakiness of such vesicles may facilitate oligonucleotide escape. 91, 116 Molecular conjugates. Nuclear proteins: By definition, are destined for the nucleus, and have been tested as nuclear delivery agents in nonviral vectors. Such proteins include protamine, high mobility group (HMG) proteins, and H1 histone, which are all characterized by a high basic amino-acid content, and thus contain natural NLSs. Protamines are small highly basic proteins with a high arginine content, and have been used to enhance lipid-mediated gene transfer. 212, 213 These naturally occurring proteins are found in sperm heads, where they compact sperm DNA for delivery to the nucleus after fertilization. In nonviral vectors, protamine efficiently compacts and protects DNA from serum nuclease degradation. 31, 43, 212 HMG proteins and histones bind chromosomal DNA, and have been incorporated with lipid vectors. 214, 215 H1 histone is imported into the nucleus from the cytosol by a facilitated transport mechanism. 216, 217 When appended to ASOR-targeted ligands and delivered to HepG2 cells, transfection by histone-containing conjugates was 11-times more effective than conjugates lacking the histone. 37 Whether the enhanced gene transfer imparted by these nuclear proteins is due to facilitated transit into the nucleus remains unclear. It is just as likely, for instance, that the ability of these proteins to effectively condense DNA, and thus provide protection against nucleases, may account for the enhanced gene transfer.
As a different approach, transcription factors, such as the GAL4 yeast transcription factor, have been used. The amino terminal DNA binding domain of GAL4 has been incorporated into a targeted molecular conjugate. 42 Unlike the nuclear proteins mentioned earlier, GAL4 recognizes a specific sequence on the DNA, thus a plasmid can be engineered to bind a fixed number of GAL4-derived proteins. Whereas the sequence-specific binding of this protein for DNA transport has been established, it is, once again, unclear whether gene transfer enhancement by GAL4 proteins is actually due to an ability to facilitate DNA translocation into the nucleus.
Viral proteins: that normally mediate nuclear delivery of viral DNA have been incorporated into nonviral vectors to facilitate nuclear import of plasmid DNA. As with the nuclear proteins described above, many of these viral proteins are positively charged, efficient at DNA condensation, and contain NLSs. A commonly used NLS, containing the sequence P 126 KKKRKV 132 is derived from the SV40 large T antigen, 218 and when bound to fluorescent plasmid DNA, was shown to facilitate DNA translocation across the nuclear envelope. 219, 220 The Ad hexon protein, when added to PEI/DNA complexes by covalent linkage to PEI, has enhanced transgene expression 10-fold. 221 Similar to whole Ad, gene transfer was inhibited by WGA, suggesting that interaction with the NPC, likely via the hexon, enables gene transfer. The core protein VII of Ad2, which normally binds viral genomic DNA and facilitates its transport into the nucleus, 222 enabled nuclear association of about 40% of applied DNA by 2-4 h after transfection, as distinguished by subcellular fractionation, 222 though it was unclear whether the DNA was actually transported into the nucleus. Vpr of HIV has both DNA condensing and nuclear targeting features that can facilitate nonviral gene transfer. 105, 106 The Epstein-Barr virus encoded protein, EBNA-1, binds importin-a. 223 It also binds an oriP site on the viral genome and retains it as an episome after infection by cobinding mitotic chromosomes. 224 This feature of EBNA-1 was evident when incorporated into a lipoplex for delivering the mdr1 gene. 225 After gene transfer, there was a greater recovery of episomes from human KB-3-1 adenocarcinoma cells and tumor explants from nude mice after drug selection. The Rep 68/78 proteins of adeno-associated virus likewise contain a nuclear localization signal in the C-terminus, which may be ultimately useful in utilizing proteins from this complex in molecular complexes. 226 Role of mitosis Lipoplexes and polyplexes. Brunner et al 227 compared the cell cycle dependence of lipoplexes and polyplexes with Ad in gene transfer efficiency. Lipofectamine, PEI, and polylysine-based vectors were tested, along with Ad and the Tf-targeted Ad, AVET. Ad-mediated gene transfer was affected little by cell cycle, as the Ad-based transduction increased only four-fold when K572 cells were transduced during the S or G2 phases versus the G1 phase. For lipoplexes or polyplexes, however, transfection during the S or G2 phases increased gene transfer 500-fold, indicating a dependence on mitosis for efficient delivery and expression. Linear PEI and lipofectamine were also compared in a study examining cell cycle independent nuclear entry. 228 For linear PEI, transfecting cells during the S/G2 phases increased gene transfer sixfold over transfection during the G1 phase. For lipofectamine, however, the same comparison produced a 100-fold difference. The authors concluded from this study that linear PEI likely had improved nuclear import capability compared to many other types of nonviral systems.
While cell division appears to enhance nonviral gene transfer, other studies have suggested that the dependence of nuclear entry on cell division is cell typespecific. Dowty et al 229 found that naked plasmid DNA injected into the cytoplasm of rat myotubes readily migrated into the nucleus. Gene transfer was decreased B20-fold by the coinjection of WGA, indicating that the plasmids entered nuclei through the nuclear pore. While the multinucleated state of myotubes may account for this enhanced nuclear targeting, interaction of karyopherins with the plasmid are likely to also contribute to nuclear entry. Ludtke et al 230 also found that cell division is not necessarily a requirement for efficient nonviral gene transfer. The cytoplasm of nondividing HeLa cells was microinjected with plasmids expressing nuclearIntracellular trafficking of nonviral vectors LK Medina-Kauwe et al targeted enhanced GFP. The authors found that 10 or 1000 ng/ml DNA entered nuclei in 28 or 50% of nondividing cells, and 50 or 90% of dividing cells, respectively. The authors concluded that DNA can enter nonmitotic nuclei albeit at a lower efficiency than mitotic nuclei.
Postnuclear events
It is unclear how and when DNA delivered by nonviral vectors is released. It is commonly thought that genomic DNA displaces the DNA condensing agents in the nucleus, thus releasing plasmid DNA and enabling gene expression. 231 However, Zabner et al 1 showed that even when lipoplexes were microinjected directly into the nucleus, gene expression was inhibited compared to naked DNA. It is likely that DNA release in the nucleus is dependent on the type of vector used, as Pollard et al 232 showed that PEI promoted nuclear delivery and DNA release in the nucleus, whereas cationic lipids did not. The demonstration that anionic lipids, as those found on the cytoplasmic face of the plasma membrane, can displace DNA from cationic liposomes supports a mechanism of DNA release in the cytoplasm as opposed to the nucleus. 146 Finally, whereas nuclear targeted proteins facilitate nuclear transport of plasmid DNA, it is unclear how efficiently these proteins release DNA once the complex arrives in the nucleus. As many of these proteins are rich in basic amino acids, they are both ideal and necessary for DNA compaction and protection outside the cell, inside the cytoplasm, and for nuclear delivery. Yet, ironically, their tight DNA binding may actually impede the function of the payload they were meant to protect.
Conclusions and future directions
Studies on the intracellular trafficking of nonviral vectors has given us valuable insights into the barriers these vectors must overcome to mediate efficient gene transfer. The attachment of receptor-specific ligands to nonviral complexes has enabled efficient cell-specific binding and entry via receptor-mediated endocytosis. Whereas the receptor targets usually undergo clathrin-dependent endocytosis, these studies have highlighted instances where the vectors themselves may be internalized, at least in part, through alternative cell entry pathways. These studies have indicated that clathrin-dependent endocytic pathways lead to lysosomal delivery, but that many vectors have incorporated acid-sensitive mechanisms of endosomolysis to prevent lysosomal degradation. These studies have also shown that alternative, nonclathrin dependent pathways avoid the lysosome but also do not support a high level of nonviral gene transfer. The complex size may be a contributing factor in determining the pathway of cell entry and intracellular trafficking. Endosomal escape mechanisms, produced synthetically or borrowed from naturally evolved systems, have been necessary components of nonviral vectors. However, the mechanisms currently incorporated into nonviral vectors usually respond to an acid environment, and thus may not enable escape from a nonclathrin mediated pathway.
Whether the DNA is released in the cytoplasm or nucleus is an important factor. Cytosolic nuclease activity can cleave unprotected DNA in the cytoplasm, preventing efficient gene transfer. On the other hand, highly basic proteins and similar analogs that bind and protect DNA well may not necessarily release DNA very readily. Perhaps efficient gene transfer by cytosolic DNA is possible as long as the DNA can associate rapidly with importin-mediated complexes and enter the nuclear pore fast enough to avoid high levels of cytosolic degradation.
By continuing to observe and understand how naturally evolved systems have overcome trafficking barriers, we may continue to apply these mechanisms to nonviral vectors and improve their capacity for gene therapy.
